Skip to main content Skip to main navigation menu Skip to site footer
logo Mediterranean Journal of Hematology and Infectious Diseases

eISSN 2035-3006

  • Home
  • About the Journal
  • Editorial Board
  • Current
  • Archives
  • Announcements
  • Register
  • Login
  • Journal Statistics
  • Search
  • Contact
  • Announcements

Editor-in-Chief: Giuseppe Leone | Italy

2.3
Impact Factor 2025
3.2
CiteScore 2025
2.3
Impact Factor 2025
3.2
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA

    Umberto Ricardi, Andrea Riccardo Filippi, Cristina Piva, Pierfrancesco Franco
    e2014035
    2014-05-30
    https://doi.org/10.4084/mjhid.2014.035
    2271
    PDF: 961
    HTML: 6798
    Figure 1: 178
  • SOLITARY PLASMACYTOMA

    Sara Grammatico, Emilia Scalzulli, Maria Teresa Petrucci
    e2017052
    2017-08-23
    https://doi.org/10.4084/mjhid.2017.052
    3945
    PDF: 2222
    HTML: 1250
    fIGURES 1,2: 232
  • HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?

    Antoine Thyss, Esma Saada, Lauris Gastaud, Frédéric Peyrade, Daniel Ré
    e2014050
    2014-07-01
    https://doi.org/10.4084/mjhid.2014.050
    2940
    PDF: 1387
    HTML: 3583
    Untitled: 200
    Untitled: 213
    Untitled: 187
  • PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries

    Dr, Moleti, Anna Maria Testi
    e2024078
    2024-10-31
    https://doi.org/10.4084/MJHID.2024.078
    1305
    PDF: 905
    HTML: 324
  • LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.

    Andrea Riccardo Filippi
    e2016041
    2016-09-01
    https://doi.org/10.4084/mjhid.2016.041
    3755
    PDF: 1122
    HTML: 2442
    Figure 1: 213
  • CLASSICAL HODGKIN LYMPHOMA TODAY

    Francesco D'Alò, Gabriele Schiaffini, Daniele Mazzoni, Eleonora Alma, Flaminia Bellisario, Marcello Viscovo, Elena Maiolo, Silvia Bellesi, Stefan Hohaus
    2026-06-30
    https://doi.org/10.4084/MJHID.2026.055
    439
    PDF: 287
    HTML: 56
  • INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER

    Caterina Giovanna Valentini, Luana Fianchi, Maria Teresa Voso, Morena Caira, Giuseppe Leone, Livio Pagano
    e2011069
    2011-12-22
    https://doi.org/10.4084/mjhid.2011.069
    3334
    PDF: 958
    HTML: 2970
  • TREATMENT OF EARLY STAGES HODGKIN LYMPHOMA DURING PREGNANCY

    Agustin Avilès, Maria-Jesus Nambo, Natividad Neri
    e2018006
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.006
    3603
    PDF: 1094
    HTML: 881
  • COMBINED MODALITY TREATMENT INCLUDING METHOTREXATE-BASED CHEMOTHERAPY FOR PRIMARY CEREBRAL NERVOUS SYSTEM LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

    Stefan Hohaus, Luciana Teofili, Mario Balducci, Stefania Manfrida, Angelo Pompucci, Francesco D'Alo', Giuseppina Massini, Luigi Maria Larocca, Roberto Marra, Sergio Storti
    e2009020
    2009-12-14
    https://doi.org/10.4084/mjhid.2009.020
    2255
    PDF: 540
    HTML: 2291
  • THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

    Xenofon Papanikolaou, Bart Barlogie, Saad Usmani
    e2011047
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.047
    2508
    PDF: 801
    HTML: 1742
  • ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication

    Maria Chiara Tisi, Giuseppe Ausoni, Maria Gabriella Vita, Tommaso Tartaglione, Mario Balducci, Luca Laurenti, Patrizia Chiusolo, Stefan Hohaus, Simona Sica
    e2015025
    2015-02-17
    https://doi.org/10.4084/mjhid.2015.025
    2421
    PDF: 1016
    HTML: 1655
    Fig 1: 195
    Tab I: 221
    Cover Letter: 213
  • SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW

    Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca
    e2016062
    2016-11-06
    https://doi.org/10.4084/mjhid.2016.062
    3827
    PDF: 1079
    HTML: 2101
  • THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY

    Ercole Brusamolino, Manuel Gotti, Valeria Fiaccadori
    e2012022
    2012-04-06
    https://doi.org/10.4084/mjhid.2012.022
    2238
    PDF: 906
    HTML: 1955
  • THE IMPACT OF THE SARS-CoV-2 PANDEMIC ON HEALTHCARE PROVISION IN ITALY TO NON-COVID PATIENTS: A SYSTEMATIC REVIEW

    Annarita Botta, Gianmarco Lugli, Matteo Maria Ottaviani, Guido Ascione, Alessandro Bruschi, Federico Cagnazzo, Lorenzo Zammarchi, Paola Romagnani, tommaso portaluri
    e2022012
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.012
    1833
    PDF: 3322
    HTML: 421
  • HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ

    Anna Maria Testi, Mazin Faisal Al-Jadiry, Maria Luisa Moleti, Stefania Uccini, Amir Fadhil Al-Darraij, Raghad Majid Al-Saeed, Hasanein Habeeb Ghali, Ahmed Hatem Sabhan, Samaher Abdulrazzaq Fadhil, Safaa Abdulelah Al-Badri, Adil Rabeea Alsaadawi, Ameer Dh Hameedi, Manhal Hashim Shanshal, Yasir Saadoon Al-Agele, Fatimah Abdul Ridha Al-Saffar, Nihal Khalid Yaseen, Alfonso Piciocchi, Giovanni Marsili, Salma Abbas Al-Hadad
    e2024053
    2024-06-29
    https://doi.org/10.4084/MJHID.2024.053
    1060
    PDF: 946
    Suppl. Files: 601
    HTML: 95
  • MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA

    Melanie Joannides, Ashley N Mays, Anita R Mistry, Syed Khizer Hasan, Andreas Reiter, Joseph L Wiemels, Carolyn A Felix, Francesco Lo-Coco, Neil Osheroff, Ellen Solomon, David Grimwade
    e2011045
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.045
    2914
    PDF: 867
    HTML: 6537
    Untitled: 245
    Untitled: 202
    Untitled: 220
    Untitled: 229
  • THERAPY-RELATED MYELOID NEOPLASM IN NON-HODGKIN LYMPHOMA SURVIVORS

    Alessia Bari, Luigi Marcheselli, Raffaella Marcheselli, Eliana Valentina Liardo, Samantha Pozzi, Stefano Sacchi
    e2011065
    2011-12-20
    https://doi.org/10.4084/mjhid.2011.065
    2679
    PDF: 763
    HTML: 2316
  • Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy

    Pasquale Niscola
    e2013030
    2013-04-16
    https://doi.org/10.4084/mjhid.2013.030
    1210
    PDF: 775
    HTML: 1484
    Figure 1: 196
    Figure 2: 198
  • The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

    Michele Bibas
    e2024015
    2024-02-29
    https://doi.org/10.4084/MJHID.2024.015
    1852
    PDF: 1725
    HTML: 904
  • THERAPY-RELATED MYELOID NEOPLASMS IN PATIENTS TREATED FOR HODGKIN LYMPHOMA

    Dennis A Eichenauer, Andreas Engert
    e2011046
    2011-10-24
    https://doi.org/10.4084/mjhid.2011.046
    2323
    PDF: 772
    HTML: 1212
  • OCCURRENCE OF SECONDARY MALIGNANCIES IN CHRONIC MYELOID LEUKEMIA DURING THERAPY WITH IMATINIB MESYLATE-SINGLE INSTITUTION EXPERIENCE

    Grzegorz Helbig, Grazyna Bober, Marek Seweryn, Ryszard Wichary, Andrzej Tukiendorf, Lech Sedlak, Tomasz Oleksy, Slawomira Kyrcz-Krzemien
    e2015003
    2015-01-01
    https://doi.org/10.4084/mjhid.2015.003
    2284
    PDF: 1068
    HTML: 1990
    Characteristic of study group: 209
  • Lenalidomide and temozolomide combination in a very elderly patient with CNS relapse of diffuse large b-cell lymphoma.

    Emanuele Cencini, Alberto Fabbri, Umberto Arrigucci, Alfonso Cerase, Monica Bocchia
    e2017040
    2017-06-16
    https://doi.org/10.4084/mjhid.2017.040
    3470
    PDF: 1058
    HTML: 1010
    Figure 1: 188
  • CURRENT ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION FOR RELAPSED AND REFRACTORY HODGKIN LYMPHOMA

    Luca Castagna, Carmelo Carlo-Stella, Rita Mazza, Armando Santoro
    e2015015
    2015-02-12
    https://doi.org/10.4084/mjhid.2015.015
    2826
    PDF: 1433
    HTML: 4633
  • GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS

    Angela Stoddart, Megan E. McNerney, Elizabeth Bartom, Rachel Bergerson, David J. Young, Zhijian Qian, Jianghong Wang, Anthony A. Fernald, Elizabeth M. Davis, Richard A. Larson, Kevin P. White, Michelle M. Le Beau
    e2011019
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.019
    2624
    PDF: 817
    HTML: 5241
  • PROLIFERATION AND APOPTOSIS OF B-CELL LYMPHOMA CELLS UNDER TARGETED REGULATION OF FOXO3 BY miR-155 miR-155, FOXO3, B-cell lymphoma, proliferation, apoptosis, clinical characteristics

    Xiaoqiang Zheng, Hongbing Rui, Ying Liu, Jinfeng Dong
    e2020073
    2020-11-02
    https://doi.org/10.4084/mjhid.2020.073
    824
    PDF: 102
    HTML: 149
  • ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THERAPY-RELATED MYELOID NEOPLASMS (t-MN) OF THE ADULT: MONOCENTRIC OBSERVATIONAL STUDY AND REVIEW OF THE LITERATURE.

    Elisabetta Metafuni, Patrizia Chiusolo, Luca Laurenti, Federica Sorà, Sabrina Giammarco, Andrea Bacigalupo, Giuseppe Leone, Simona Sica
    e2018005
    2018-01-01
    https://doi.org/10.4084/mjhid.2018.005
    4232
    PDF: 1101
    HTML: 1370
  • OUTCOME OF PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA RELAPSING AFTER AUTOLOGOUS TRANSPLANT BEFORE AVAILABILITY OF CAR-T CELL TREATMENT Outcome of DLBCL patients relapsing after ASCT

    Ulrike Bacher, Stefanie von Matt, Yara Banz, Behrouz Mansouri, Urban Novak, Thomas Pabst
    e2023025
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.025
    1378
    HTML: 333
    PDF: 964
    Suppl. Files: 473
  • ADVANCED HODGKIN LYMPHOMA: A NEW ERA OF THERAPY

    Eldad J Dann
    e2014063
    2014-09-05
    https://doi.org/10.4084/mjhid.2014.063
    2159
    PDF: 1336
    HTML: 3507
  • INFECTIOUS AETIOLOGY OF MARGINAL ZONE LYMPHOMA AND ROLE OF ANTI-INFECTIVE THERAPY

    Salvatore Perrone, Gianna Maria D'Elia, Alessandro Pulsoni
    e2016006
    2016-01-01
    https://doi.org/10.4084/mjhid.2016.006
    4483
    PDF: 1367
    HTML: 2169
  • NASAL NK/T- CELL LYMPHOMA. COMPARATIVE ANALYSIS OF A MEXICAN POPULATION

    Augustine Avilès
    e2015052
    2015-08-30
    https://doi.org/10.4084/mjhid.2015.052
    1800
    PDF: 1008
    HTML: 1795
    Tables: 183
  • OUTCOME AND TOXICITY PATTERNS IN CHILDREN AND ADOLESCENTS WITH NON-HODGKIN LYMPHOMA: A SINGLE INSTITUTION EXPERIENCE

    Paola Angelini, Laura Rodriguez, Mohammed Zolaly, Ahmed Naqvi, Sheila Weitzman, oussama Abla, Angela Punnett
    e2018020
    2018-03-01
    https://doi.org/10.4084/mjhid.2018.020
    2903
    PDF: 852
    HTML: 381
  • DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES

    Prof. Giuseppe Leone, Emiliano Fabiani, Maria Teresa Voso
    e2022030
    2022-04-28
    https://doi.org/10.4084/MJHID.2022.030
    1419
    HTML: 482
    PDF: 844
  • EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES

    Kjeld Schmiegelow
    e2011020
    2011-05-16
    https://doi.org/10.4084/mjhid.2011.020
    2264
    PDF: 833
    HTML: 1640
    Figure 1: 205
    Table 1: 222
  • FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT

    Alessia Castellino, Umberto Vitolo
    e2017009
    2017-01-01
    https://doi.org/10.4084/mjhid.2017.009
    4474
    PDF: 1657
    HTML: 4079
    Tables and Images: 241
  • POEMS SYNDROME: AN UPDATE

    Andrea Nozza
    e2017051
    2017-09-01
    https://doi.org/10.4084/mjhid.2017.051
    3391
    PDF: 1671
    HTML: 1531
  • EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN

    Massimiliano Salati, Marina Cesaretti, Matteo Macchia, Mufid El Mistiri, Massimo Federico
    e2014048
    2014-06-29
    https://doi.org/10.4084/mjhid.2014.048
    3592
    PDF: 1245
    HTML: 5008
    Incidence age-standardized rates for HL across the Mediterranean basin: 213
  • THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML

    Dr. Palmieri, Ilaria Del Principe, Dr. Maurillo, Prof. Venditti, Francesco Buccisano
    e2023051
    2023-08-29
    https://doi.org/10.4084/MJHID.2023.051
    1782
    PDF: 835
    HTML: 179
  • TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML

    Ugo Testa, Dr. Germana Castelli, Dr. Elvira Pelosi
    e2023038
    2023-06-29
    https://doi.org/10.4084/MJHID.2023.038
    2198
    PDF: 1737
    HTML: 385
  • Complete Remission Obtained with Azacitidine in a Patient with Concomitant Therapy Related Myeloid Neoplasm and Pulmonary Mucormycosis

    Saveria Capria, Federico De Angelis, Giuseppe Gentile, Silvia Maria Trisolini, Simonetta Brocchieri, Martina Canichella, Patrizia Chiusolo, Alessandra Micozzi, Robin Foà, Giovanna Meloni
    e2013048
    2013-07-10
    https://doi.org/10.4084/mjhid.2013.048
    1587
    PDF: 696
    HTML: 1926
  • CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,

    Ugo Testa, Giuseppe Leone, Elvira Pelosi, Dr. Germana Castelli, Prof. Hohaus
    e2023066
    2023-10-30
    https://doi.org/10.4084/MJHID.2023.066
    3769
    PDF: 1492
    HTML: 190
  • Direct oral anticoagulants (DOACs) in the onco-hematologic patients

    Mario Biglietto, Silvio Ligia, Alessandro Laganà, Giovanni Manfredi Assanto, Martina Gherardini, Erminia Baldacci, Cristina Santoro, Antonio Chistolini
    e2025022
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.022
    1054
    PDF: 1032
    HTML: 127
  • ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children

    Ilaria Lazzareschi, Elena Rossi, Antonietta Curatola, Giovanna Capozio, Luca Benacquista, Ludovica Iezzi, Donato Rigante
    e2022008
    2022-01-01
    https://doi.org/10.4084/MJHID.2022.008
    2340
    PDF: 1192
    HTML: 656
  • An Urologic Face of Chronic Lymphocytic Leukemia:Sequential Prostatic and Penis Localization

    Giovanni D'Arena, Roberto Guariglia, Oreste Villani, Maria Carmen Martorelli, Giuseppe Pietrantuono, Giovanna Mansueto, Giuseppe Patitucci, Emilio Imbriani, Tommaso Masciandaro, Ludovica Borgia, Giulia Vita, Fiorella D'Auria, Teodora Statuto, Pellegrino Musto
    e2013008
    2013-01-02
    https://doi.org/10.4084/mjhid.2013.008
    1589
    PDF: 1119
    HTML: 2964
  • BING-NEEL SYNDROME: ILLUSTRATIVE CASES AND COMPREHENSIVE REVIEW OF THE LITERATURE

    Marzia Varettoni, Irene Defrancesco, Luca Diamanti, Enrico Marchioni, Lisa Maria Farina, Anna Pichiecchio
    e2017061
    2017-10-18
    https://doi.org/10.4084/mjhid.2017.061
    3520
    PDF: 1520
    HTML: 1334
  • Achieving the cure of follicular lymphoma: is it time to finalize treatment strategies to reach this goal in a subset of patients?

    Mauro Passucci, Giovanni Assanto, Alessandro Pulsoni
    e2023018
    2023-02-28
    https://doi.org/10.4084/MJHID.2023.018
    1283
    PDF: 930
    HTML: 368
  • Leukemia cutis in a patient with acute myeloid leukemia undergoing Azacitidine-Venetoclax: case presentation and review of the literature

    Elisa Buzzatti, Cristina Mauro, Caterina Botti, Roberta Presicci, Giovangiacinto Paterno, Raffaele Palmieri, Carmelo Gurnari, Flavia Mallegni, Elisa Meddi, Federico Moretti, Lucia Cardillo, Valeria Mezzanotte, Kristian Taka, Lucrezia De Marchi, Luca Maurillo, Francesco Buccisano, Adriano Venditti, Maria Ilaria Del Principe
    e2025013
    2025-02-27
    https://doi.org/10.4084/MJHID.2025.013
    1018
    PDF: 1131
    HTML: 124
  • TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin

    Cristina Papayannidis, Vincenzo Federico, Luana Fianchi, Patrizia Pregno, Novella Pugliese, Alessandra Romano, Federica Irene Grifoni
    e2022073
    2022-10-29
    https://doi.org/10.4084/MJHID.2022.073
    1288
    PDF: 1033
    HTML: 233
  • UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANT IN FOLLICULAR LYMPHOMAS

    Mónica Cabrero, Alba Redondo, Alejandro Martin, Dolores Caballero
    e2012074
    2012-11-07
    https://doi.org/10.4084/mjhid.2012.074
    2198
    PDF: 746
    HTML: 1078
  • CLINICAL CHARACTERISTICS AND PROGNOSTIC FACTORS IN PRIMARY BREAST DIFFUSE LARGE B-CELL LYMPHOMA

    guangliang Chen, Dou-dou Li, Sufen Sufen, Shiyu Jiang, Qunling Zhang, jia jin, Zuguang Xia, Yizhen Liu, Xiaojian Liu, Yanzhe Zhu, Yu Chen, Lingli Gu, Xiaonan Hong, Junning Cao, Rong Tao, Fangfang Lv
    e2022066
    2022-08-27
    https://doi.org/10.4084/MJHID.2022.066
    1052
    PDF: 656
    HTML: 248
  • Kaposi Sarcoma in people living with HIV: is it water under the bridge?

    chiara papalini, Lucia Brescini, Laura Curci, Sabrina Bastianelli, Francesco Barchiesi, Andrea Giacometti, Daniela Francisci
    e2023027
    2023-04-28
    https://doi.org/10.4084/MJHID.2023.027
    935
    PDF: 770
    HTML: 306
1 - 50 of 104 items 1 2 3 > >> 
Make a Submission

Links

  • Editorial Board
  • Alert me!
  • Advertising
  • Scopus
  • DOAJ
  • Article Processing Charge

Information

  • For Readers
  • For Authors
  • For Librarians

Indexing

  • OpenAlex
  • Analytics

PubMed

MJHID CiteScore by Scopus

Clarivate Analytics

this journal is covered
by Clarivate Analytics

 

The Mediterranean Journal of Hematology and Infectious Diseases has been selected for coverage in Clarivate Analytics products and services. Beginning with V. 7 (1) 2015.

AskBisht

Indexed in AskBisht.com

Facebook

FOLLOW US

MJHID in EuroPub Database

EuroPub

CLL UpDate

Keywords

Mediterranean Journal of Hematology and Infectious Diseases

is owned by the U.C.S.C. and it is published by PAGEPress®, Pavia, Italy. The MJHID is indexed and abstracted in Science Citation Index Expanded and Journal Citation Reports/InCites beginning with V. 7 (1) 2015.

eISSN: 2035-3006

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.